0%), inklusive KOL- exacerbation (1 ud af 37 patienter [2, 7%]) og bronkitis (1 ud af 37 patienter [2, 7%]).
0%), including COPD exacerbation (1 of 37 patients [2.7%]) and bronchitis (1 of 37 patients [2.7%]).